Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma - 21/03/19
Abstract |
Background and Aims |
Pancreatic intraepithelial neoplasia is associated with chronic pancreatitis (CP) changes on EUS. The objective of this study was to determine whether CP changes were more common in high-risk individuals (HRIs) than in control subjects and whether these changes differed among higher-risk subsets of HRIs.
Methods |
HRIs and control subjects were identified from an endoscopy database. HRIs were defined as having predisposing mutations or a family history (FH) of pancreatic ductal adenocarcinoma. HRIs were classified as vHRIs who met Cancer of the Pancreas Screening (CAPS) criteria for high risk and mHRIs who did not. Multivariable logistic regression was used to adjust for confounders and CP risk factors.
Results |
Sixty-five HRIs (44 vHRIs, 21 mHRIs) and 118 control subjects were included. HRIs were included for FH (25), Lynch syndrome (5), Peutz-Jeghers syndrome (2), and mutations in BRCA1/2 (26), PALB2 (3), ATM (3), and CDKN2A (1). After adjustment for relevant variables, HRIs were 16 times more likely to exhibit 3 or more CP changes than control subjects (95% confidence interval, 2.6-97.0; P = .003). HRIs were also more likely to have hypoechoic foci (odds ratio, 8.0; 95% confidence interval, 1.9-32.9; P = .004). vHRIs and mHRIs did not differ in frequency of 3 or more CP changes on EUS.
Conclusions |
HRIs were more likely to exhibit CP changes and hypoechoic foci on EUS compared with control subjects. HRIs with these findings may require closer surveillance. HRIs who did or did not meet CAPS criteria did not differ with regard to CP findings, supporting a more inclusive approach to screening.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations : BMI, CAPS, CP, CI, FDR, FH, HRI, LS, mHRI, OR, PanIN, PDAC, PJS, vHRI
Mappa
| DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. Research support for this study was provided to W.G. Park by theNational Institutes of Health(grant no.1 U01 CA210020-01A1). |
|
| See CME section; p. 889. |
|
| If you would like to chat with an author of this article, you may contact Dr Thiruvengadam at sujan702@stanford.edu. |
Vol 89 - N° 4
P. 842 - aprile 2019 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
